- Home
- DDD vs NPCE Comparison
DDD vs NPCE Comparison
Compare DDD & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDD
- NPCE
- Stock Information
- Founded
- DDD 1986
- NPCE 1997
- Country
- DDD United States
- NPCE United States
- Employees
- DDD N/A
- NPCE N/A
- Industry
- DDD Computer peripheral equipment
- NPCE Medical Specialities
- Sector
- DDD Technology
- NPCE Health Care
- Exchange
- DDD Nasdaq
- NPCE Nasdaq
- Market Cap
- DDD 360.4M
- NPCE 342.7M
- IPO Year
- DDD N/A
- NPCE 2021
- Fundamental
- Price
- DDD $3.16
- NPCE $10.62
- Analyst Decision
- DDD Buy
- NPCE Strong Buy
- Analyst Count
- DDD 2
- NPCE 6
- Target Price
- DDD $5.00
- NPCE $16.67
- AVG Volume (30 Days)
- DDD 4.5M
- NPCE 164.8K
- Earning Date
- DDD 11-25-2025
- NPCE 11-11-2025
- Dividend Yield
- DDD N/A
- NPCE N/A
- EPS Growth
- DDD N/A
- NPCE N/A
- EPS
- DDD N/A
- NPCE N/A
- Revenue
- DDD $413,342,000.00
- NPCE $88,570,000.00
- Revenue This Year
- DDD N/A
- NPCE $22.13
- Revenue Next Year
- DDD $1.78
- NPCE $6.07
- P/E Ratio
- DDD N/A
- NPCE N/A
- Revenue Growth
- DDD N/A
- NPCE 23.32
- 52 Week Low
- DDD $1.32
- NPCE $5.45
- 52 Week High
- DDD $5.00
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- DDD 72.25
- NPCE 61.86
- Support Level
- DDD $2.80
- NPCE $9.76
- Resistance Level
- DDD $3.29
- NPCE $11.13
- Average True Range (ATR)
- DDD 0.27
- NPCE 0.44
- MACD
- DDD 0.03
- NPCE 0.04
- Stochastic Oscillator
- DDD 72.29
- NPCE 62.77
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.